Works matching IS 1470269X AND DT 2009 AND VI 9 AND IP 4

Results: 9

Global variation in CYP2C8–CYP2C9 functional haplotypes.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 283, doi. 10.1038/tpj.2009.10

By:

Speed, William C.;
Kang, Soonmo Peter;
Tuck, David P.;
Harris, Lyndsay N.;
Kidd, Kenneth K.

Publication type:

Article

A novel CYP2A6 allele (CYP2A6<sup>*</sup>35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 274, doi. 10.1038/tpj.2009.11

By:

Al Koudsi, Nael;
Ahluwalia, Jasjit S.;
Shih-Ku Lin;
Sellers, Edward M.;
Tyndale, Rachel F.

Publication type:

Article

Genetic predictors of response to antidepressants in the GENDEP project.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 225, doi. 10.1038/tpj.2009.12

By:

Uher, Rudolf;
Huezo-Diaz, Patricia;
Perroud, Nader;
Smith, Rebecca;
Rietschel, Marcella;
Mors, Ole;
Hauser, Joanna;
Maier, Wolfgang;
Kozel, Dejan;
Henigsberg, Neven;
Barreto, Mara;
Placentino, Anna;
Dernovsek, Mojca Zvezdana;
Schulze, Thomas G.;
Kalember, Petra;
Zobel, Astrid;
Czerski, Piotr M.;
Larsen, Erik Roj;
Souery, Daniel;
Giovannini, Caterina

Publication type:

Article

A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 265, doi. 10.1038/tpj.2009.13

By:

Demacq, C.;
Vasconcellos, V. B.;
Marcaccini, A. M.;
Gerlach, R. F.;
Machado, A. A.;
Tanus-Santos, J. E.

Publication type:

Article

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 258, doi. 10.1038/tpj.2009.14

By:

Rae, J. M.;
Sikora, M. J.;
Henry, N. L.;
Li, L.;
Kim, S.;
Oesterreich, S;
Skaar, T. C.;
Nguyen, A. T.;
Desta, Z.;
Storniolo, A. M.;
Flockhart, D. A.;
Hayes, D. F.;
Stearns, V.

Publication type:

Article

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 242, doi. 10.1038/tpj.2009.15

By:

Becker, M. L.;
Visser, L. E.;
Schaik, R. H. N. van;
Hofman, A.;
Uitterlinden, A. G.;
Stricker, B. H. C.

Publication type:

Article

Olanzapine-induced weight gain is associated with the −759C/T and −697G/C polymorphisms of the HTR2C gene.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 234, doi. 10.1038/tpj.2009.18

By:

Godlewska, B. R.;
Olajossy-Hilkesberger, L.;
Ciwoniuk, M.;
Olajossy, M.;
Marmurowska-Michałowska, H.;
Limon, J.;
Landowski, J.

Publication type:

Article

APOE gene polymorphisms and response to statin therapy.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 248, doi. 10.1038/tpj.2009.25

By:

Zintzaras, E.;
Kitsios, G. D.;
Triposkiadis, F.;
Lau, J.;
Raman, G.

Publication type:

Article

Association of nicotinic acetylcholine receptor subunit α4 polymorphisms with nicotine dependence in 5500 Germans.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 219, doi. 10.1038/tpj.2009.6

By:

Breitling, L. P.;
Dahmen, N.;
Mittelstraß, K;
Rujescu, D.;
Gallinat, J.;
Fehr, C.;
Giegling, I.;
Lamina, C.;
Illig, T.;
Müller, H.;
Raum, E.;
Rothenbacher, D.;
Wichmann, H.-E.;
Brenner, H.;
Winterer, G.

Publication type:

Article